Search Results - Struyf, Lars

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Faster and more intelligent object detection by combining OpenCL and KR

    Faster and more intelligent object detection by combining OpenCL and KR by De Smedt, Floris, Struyf, Lars, Beckers, Sander, Vennekens, Joost, De Samblanx, Gorik, Goedemé, Toon

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells

    A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells by Fonseca, Pedro, Cui, Weiyingqi, Struyf, Nona, Tong, Le, Chaurasiya, Ayushi, Casagrande, Felipe, Zhao, Honglei, Fernando, Dinura, Chen, Xinsong, Tobin, Nicholas P, Seashore-Ludlow, Brinton, Lundqvist, Andreas, Hartman, Johan, Göndör, Anita, Östling, Päivi, Holmgren, Lars

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Human DOCK2 Deficiency: Report of a Novel Mutation and Evidence for Neutrophil Dysfunction

    Human DOCK2 Deficiency: Report of a Novel Mutation and Evidence for Neutrophil Dysfunction by Moens, Leen, Gouwy, Mieke, Bosch, Barbara, Pastukhov, Oleksandr, Nieto-Patlàn, Alejandro, Siler, Ulrich, Bucciol, Giorgia, Mekahli, Djalila, Vermeulen, François, Desmet, Lars, Maebe, Sophie, Flipts, Helena, Corveleyn, Anniek, Moshous, Despina, Philippet, Pierre, Tangye, Stuart G., Boisson, Bertrand, Casanova, Jean-Laurent, Florkin, Benoit, Struyf, Sofie, Reichenbach, Janine, Bustamante, Jacinta, Notarangelo, Luigi D., Meyts, Isabelle

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial

    Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls... by Leung, Ting Fan, Liu, Anthony Pak-Yin, Lim, Fong Seng, Thollot, Franck, Oh, Helen May Lin, Lee, Bee Wah, Rombo, Lars, Tan, Ngiap Chuan, Rouzier, Roman, De Simoni, Stéphanie, Suryakiran, Pemmaraju, Hezareh, Marjan, Thomas, Florence, Folschweiller, Nicolas, Struyf, Frank

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial

    Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in gi... by Leung, Ting Fan, Liu, Anthony Pak-Yin, Lim, Fong Seng, Thollot, Franck, Oh, Helen May Lin, Lee, Bee Wah, Rombo, Lars, Tan, Ngiap Chuan, Rouzier, Roman, Friel, Damien, De Muynck, Benoit, De Simoni, Stéphanie, Suryakiran, Pemmaraju, Hezareh, Marjan, Folschweiller, Nicolas, Thomas, Florence, Struyf, Frank

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells

    A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells by Fonseca, Pedro, Cui, Weiyingqi, Struyf, Nona, Tong, Le, Chaurasiya, Ayushi, Casagrande, Felipe, Zhao, Honglei, Fernando, Dinura, Chen, Xinsong, Tobin, Nicholas P, Seashore-Ludlow, Brinton, Lundqvist, Andreas, Hartman, Johan, Göndör, Anita, Östling, Päivi, Holmgren, Lars

    Request full text
    Article
    Save to List
    Saved in:

Search Tools: